Bortezomib, sold under the brand name Velcade among others, is an anti-cancer medication used to treat multiple myeloma and mantle cell lymphoma.[1] This includes multiple myeloma in those who have and have not previously received treatment. It is generally used together with other medications.[2] See also Bortezomib.
Bortezomib is an N-protected dipeptide and can be written as , which stands for instead of a carboxylic acid.
2f16.